Search for: "SANOFI INC." Results 61 - 80 of 436
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Announcement of opinions for Thursday, May 18 (complete)
17 May 2023, 9:00 pm by SCOTUSblog
Sanofi, Andy Warhol Foundation for Visual Arts, Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Amgen v. Sanofi and Regeneron: Japan IP High Court overrules its own decision on validity of Amgen patent
15 May 2023, 1:47 am by Mami Hino (Abe, Ikubo & Katayama) and Naho Ebata (Abe, Ikubo & Katayama)
On January 26, 2023, Regeneron Pharmaceuticals, Inc., who sought to invalidate Amgen Inc. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
Petitioner’s Failure to Argue that Prior Art was Analogous to Challenged Patent Results in Reversal of IPR Decision
11 May 2023, 10:12 am by Holman
By Chris Holman Sanofi-Aventis Deutschland GMBH v. [read post]
Patently-O - https://patentlyo.com
Supreme Court Holds Over Two Patent Cases, Considers Two More on Patent Eligibility
1 May 2023, 10:11 am by Dennis Crouch
Sanofi case, argued in March 2023. [read post]
Patently-O - https://patentlyo.com
Functional Claims: Morse, Halliburton & Amgen
27 Apr 2023, 11:51 am by Dennis Crouch
The pending Supreme Court case of Amgen Inc. v. [read post]
Patently-O - https://patentlyo.com
Court concerned about scope of patent covering millions of antibodies
29 Mar 2023, 12:09 pm by Eric M. Fraser
ShareDuring oral argument in Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Court to decide how specific a patent disclosure must be
23 Mar 2023, 11:41 am by Eric M. Fraser
In Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Regents of the University of Minnesota v. Gilead Sciences, Inc. (Fed. Cir. 2023)
7 Mar 2023, 9:16 pm by Patent Docs
Sanofi may be the most closely watched patent case since AMP v. [read post]
Patent Docs - http://www.patentdocs.org/
Laundry Lists of Components are Insufficient Written Description for a Particular Combination
7 Mar 2023, 8:33 pm by Dennis Crouch
Gilead Scis., Inc., 2021-2168, — F.4th — (Fed. [read post]
Patently-O - https://patentlyo.com
"maximum strength" OTC claim plausibly misleading where prescription strength was stronger
6 Mar 2023, 5:06 am by Rebecca Tushnet
Inc. v. [read post]
43(B)log - http://tushnet.blogspot.com/
Patently Strategic: SCOTUS in Focus – Amgen v. Sanofi and the Future of Pharma Patents
1 Mar 2023, 4:15 am by Ashley Sloat
Sanofi on March 27. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Patently Strategic: SCOTUS in Focus – Amgen v. Sanofi and the Future of Pharma Patents
1 Mar 2023, 4:15 am by Ashley Sloat
Sanofi on March 27. [read post]
IPWatchdog - http://www.ipwatchdog.com/
Resurrecting the Dead: Sanofi Aventis v. HHS
7 Feb 2023, 12:00 pm by Bernard Bell
Sanofi Adventis v. [read post]
Notice & Comment - https://www.yalejreg.com/nc/
The Antitrust Week In Review
19 Jan 2023, 10:19 am by Zak Gowen
  A Washington, D.C. appeals court rejected a lawsuit by Novartis AG’s Sandoz Inc that could have given it the sole right to make a generic version of Sanofi S.A. [read post]
Antitrust Today - https://constantinecannon.com/practice/antitrust-litigation-counseling/antitrust-today/
Amici Filings in Amgen Encourage the Supreme Court to Correct the Federal Circuit’s ‘Unworkable’ Enablement Standard
5 Jan 2023, 10:43 am by Steve Brachmann
Supreme Court on the question presented by Amgen Inc. v. [read post]
IPWatchdog - http://www.ipwatchdog.com/
Amici Filings in Amgen Encourage the Supreme Court to Correct the Federal Circuit’s ‘Unworkable’ Enablement Standard
5 Jan 2023, 10:43 am by Steve Brachmann
Supreme Court on the question presented by Amgen Inc. v. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Supreme Court Patent Law 2023
22 Dec 2022, 7:59 am by Dennis Crouch
Sanofi, No. 21-757, with merits briefs due beginning December 27, 2022. [read post]
Patently-O - https://patentlyo.com
Fighting Fraud in Health Care Through the False Claims Act in the Third Circuit
5 Dec 2022, 1:03 pm by Edward T. Kang and Kandis Kovalsky
Sanofi U.S. [read post]
Kang Haggerty Firm News. - https://www.khflaw.com/news/
IPO Webinar on Enablement and Written Description
27 Nov 2022, 8:10 pm by Patent Docs
Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Larry Coury of Regeneron Pharmaceuticals, Inc.; Stephanie Donahue of Sanofi; Henry Hadad of Bristol-Meyers Squibb Co.; and Stuart Watt of Amgen, Inc. that will discuss the issues and arguments concerning the current state of enablement and written description law and where the law may be headed. [read post]
Patent Docs - http://www.patentdocs.org/
After Granting Certiorari In Enablement Case, Supreme Court Declines Opportunity To Address Written Description
11 Nov 2022, 9:40 am by Holman
Cir. 2021); Plexxikon Inc. v. [read post]
Patently-O - https://patentlyo.com